Offering services for nonclinical and feasibility studies. Includes details of device and technology assessments, business development and reimburstments. Vacaville, California, USA.
Provides preclinical, in vivo behavioral pharmacology research and testing to better understand the behavioral effects of compounds during the earliest phases of drug development. In Solana Beach, CA.
Provides predictive screening of new therapies for chronic neurodegenerative diseases, such as Alzheimer's disease, and other neuropsychiatric disorders, such as schizophrenia, depression and anxiety. In Toronto, Canada.
Offers preclinical evaluation of novel anti-tumor agents using xenograft, orthotopic, and transgenic animal models, and employing a wide array of novel molecular imaging technologies. In Ann Arbor, MI.
Provides support to the pharmaceutical drug formulation process and patent protection/litigation through conventional and advanced solid-state surface analyses. In Nottingham, UK.
A network of University-based scientists in Canada, the United States, and Europe conducting studies in accredited facilities [GLP-compliant or investigatory (pre-IND)].
Customized methods to measure biomarkers relevant to drug efficacy, toxicity and disease. Leading edge applications utilize extensive experience in assay development, optimization, performance validation, clinical utility assessment and regulatory approval
Offers permeation studies for the characterization of drugs on both human cell cultures and animal tissue. Located in Germany.
Specializes in ophthalmology pre-clinical studies and offers full services with the departments of pre-clinical research, basic research and bio-analysis.
Offers drug and xenobiotic hemotoxicity and immunotoxicity screening, hematopoietic and immune cell modulation assay services, phenotypic characterization, validation studies and rodent in vivo testing. Located in Vancouver, Canada.
|